Nantahala Capital Management »

Medifast shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Medifast (MED) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Medifast

Tip: Access up to 7 years of quarterly data

All positions including Medifast held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medifast by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $3.1M 30k 103.67
2022-12-31 $3.5M 30k 115.35
2020-06-30 $38M 273k 138.77
2020-03-31 $17M 273k 62.50
2019-12-31 $14M 130k 109.58
2019-09-30 $13M 121k 103.63

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Medifast

Vanguard Group
Pacer Advisors
Citadel Advisors
Dimensional Fund Advisors
Man Group
Bank of New York Mellon
Charles Schwab Investment Management
Hotchkis and Wiley Capital Management
Jacobs Levy Equity Management
AQR Capital Management
UBS Group
Millennium Management
Jpmorgan Chase & Co
Norges Bank Investment Management
Principal Financial Group

View all funds holding Medifast